Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
6.45
-0.38 (-5.56%)
At close: Apr 28, 2026, 4:00 PM EDT
6.50
+0.05 (0.78%)
After-hours: Apr 28, 2026, 6:51 PM EDT
Harvard Bioscience Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Harvard Bioscience stock have an average target of 18, with a low estimate of 6.00 and a high estimate of 30. The average target predicts an increase of 179.07% from the current stock price of 6.45.
Analyst Consensus: Buy
* Price targets were last updated on Mar 16, 2026.
Analyst Ratings
The average analyst rating for Harvard Bioscience stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Buy Maintains $0.6 → $6 | Buy | Maintains | $0.6 → $6 | -6.98% | Mar 16, 2026 |
| Benchmark | Benchmark | Buy Maintains $2 → $0.6 | Buy | Maintains | $2 → $0.6 | -90.70% | Mar 13, 2026 |
| Benchmark | Benchmark | Buy Maintains $30 → $20 | Buy | Maintains | $30 → $20 | +210.08% | Sep 10, 2025 |
| Benchmark | Benchmark | Buy Maintains $45 → $30 | Buy | Maintains | $45 → $30 | +365.12% | May 13, 2025 |
| Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Apr 9, 2025 |
Financial Forecast
Revenue This Year
90.68M
from 86.55M
Increased by 4.77%
Revenue Next Year
98.43M
from 90.68M
Increased by 8.55%
EPS This Year
-1.49
from -12.80
EPS Next Year
0.08
from -1.49
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 93.7M | 101.3M |
| Avg | 90.7M | 98.4M |
| Low | 86.8M | 94.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | 8.2% | 11.7% |
| Avg | 4.8% | 8.5% |
| Low | 0.3% | 4.3% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | 0.02 | 0.08 |
| Avg | -1.49 | 0.08 |
| Low | -2.88 | 0.08 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.